Literature DB >> 10516649

Cannabinoid agonists and antagonists discriminated by receptor binding in rat cerebellum.

G Griffin1, E J Wray, B R Martin, M E Abood.   

Abstract

1. The effect of allosteric regulators on the binding affinity of a number of cannabinoid receptor ligands of varying efficacy in the rat cerebellum was investigated. 2. Radioligand ([3H]-SR141716A) competition curves were constructed in the presence or absence of sodium ions, magnesium ions and guanine nucleotides. 3. It was found that the presence of these allosteric regulators did not affect the affinity of the two antagonists used but did cause a significant decrease in the affinity of full and partial agonists. 4. This reduction in affinity ranged from a 3.67 fold rightward shift of the displacement curve of a mixed agonist/antagonist (3-(6-cyano-2-hexynyl)-delta-8-tetrahydrocannabinol-O-823) to a 38 fold rightward shift for 3-(1, 1-dimethyl-6-dimethylcarboxamide)-delta-8-tetrahydrocannabinol (O-1125), a full agonist. 5. In summary, the results of this study suggest a simple method for the inference of functional data using the classical radioligand binding assay.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10516649      PMCID: PMC1571656          DOI: 10.1038/sj.bjp.0702806

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  20 in total

1.  Evaluation of cannabinoid receptor agonists and antagonists using the guanosine-5'-O-(3-[35S]thio)-triphosphate binding assay in rat cerebellar membranes.

Authors:  G Griffin; P J Atkinson; V M Showalter; B R Martin; M E Abood
Journal:  J Pharmacol Exp Ther       Date:  1998-05       Impact factor: 4.030

2.  Evaluation of binding in a transfected cell line expressing a peripheral cannabinoid receptor (CB2): identification of cannabinoid receptor subtype selective ligands.

Authors:  V M Showalter; D R Compton; B R Martin; M E Abood
Journal:  J Pharmacol Exp Ther       Date:  1996-09       Impact factor: 4.030

3.  SR 144528, the first potent and selective antagonist of the CB2 cannabinoid receptor.

Authors:  M Rinaldi-Carmona; F Barth; J Millan; J M Derocq; P Casellas; C Congy; D Oustric; M Sarran; M Bouaboula; B Calandra; M Portier; D Shire; J C Brelière; G L Le Fur
Journal:  J Pharmacol Exp Ther       Date:  1998-02       Impact factor: 4.030

4.  Opiate agonists and antagonists discriminated by receptor binding in brain.

Authors:  C B Pert; G Pasternak; S H Snyder
Journal:  Science       Date:  1973-12-28       Impact factor: 47.728

5.  Agonist-antagonist characterization of 6'-cyanohex-2'-yne-delta 8-tetrahydrocannabinol in two isolated tissue preparations.

Authors:  R G Pertwee; S R Fernando; G Griffin; W Ryan; R K Razdan; D R Compton; B R Martin
Journal:  Eur J Pharmacol       Date:  1996-11-14       Impact factor: 4.432

6.  SR141716A, a potent and selective antagonist of the brain cannabinoid receptor.

Authors:  M Rinaldi-Carmona; F Barth; M Héaulme; D Shire; B Calandra; C Congy; S Martinez; J Maruani; G Néliat; D Caput
Journal:  FEBS Lett       Date:  1994-08-22       Impact factor: 4.124

7.  An investigation into the structural determinants of cannabinoid receptor ligand efficacy.

Authors:  G Griffin; E J Wray; W K Rorrer; P J Crocker; W J Ryan; B Saha; R K Razdan; B R Martin; M E Abood
Journal:  Br J Pharmacol       Date:  1999-04       Impact factor: 8.739

8.  Comparative receptor binding analyses of cannabinoid agonists and antagonists.

Authors:  B F Thomas; A F Gilliam; D F Burch; M J Roche; H H Seltzman
Journal:  J Pharmacol Exp Ther       Date:  1998-04       Impact factor: 4.030

9.  Differential receptor-G-protein coupling evoked by dissimilar cannabinoid receptor agonists.

Authors:  D B Houston; A C Howlett
Journal:  Cell Signal       Date:  1998-10       Impact factor: 4.315

10.  Differential requirements of sodium for coupling of cannabinoid receptors to adenylyl cyclase in rat brain membranes.

Authors:  M A Pacheco; S J Ward; S R Childers
Journal:  J Neurochem       Date:  1994-05       Impact factor: 5.372

View more
  3 in total

1.  Structural dynamics and energetics underlying allosteric inactivation of the cannabinoid receptor CB1.

Authors:  Jonathan F Fay; David L Farrens
Journal:  Proc Natl Acad Sci U S A       Date:  2015-06-22       Impact factor: 11.205

2.  Vascular pharmacology of a novel cannabinoid-like compound, 3-(5-dimethylcarbamoyl-pent-1-enyl)-N-(2-hydroxy-1-methyl-ethyl)benzamide (VSN16) in the rat.

Authors:  P M Hoi; C Visintin; M Okuyama; S M Gardiner; S S Kaup; T Bennett; D Baker; D L Selwood; C R Hiley
Journal:  Br J Pharmacol       Date:  2007-09-24       Impact factor: 8.739

3.  The Structure-Function Relationships of Classical Cannabinoids: CB1/CB2 Modulation.

Authors:  Eric W Bow; John M Rimoldi
Journal:  Perspect Medicin Chem       Date:  2016-06-28
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.